MCKENNA ELIZABETH has a total of 34 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, environmental technology and foods and drinks are BIOEOS LTD, D2 BIOSCIENCE GROUP LTD and GLIA LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | African Regional Industrial Property Organization | 2 | |
#5 | Australia | 2 | |
#6 | Canada | 2 | |
#7 | China | 2 | |
#8 | Hong Kong | 2 | |
#9 | Japan | 2 | |
#10 | Republic of Korea | 2 | |
#11 | Singapore | 2 | |
#12 | Argentina | 1 | |
#13 | Costa Rica | 1 | |
#14 | Israel | 1 | |
#15 | New Zealand | 1 | |
#16 | Peru | 1 | |
#17 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Foods and drinks | |
#4 | Biotechnology | |
#5 | Measurement | |
#6 | Computer technology | |
#7 | IT methods for management |
# | Name | Total Patents |
---|---|---|
#1 | Mckenna Elizabeth | 29 |
#2 | Elizabeth Mckenna | 3 |
#3 | Mckenna Warren | 1 |
Publication | Filing date | Title |
---|---|---|
US2017232047A1 | Control of Cellular Redox Levels | |
AU2016352986A1 | Control of cellular redox levels | |
US2017039662A1 | System and process for managing the complete life cycle of a grievance complaint or arbitration request | |
EP2898073A1 | Naturally occurring cpg oligonucleotide compositions and therapeutic applications thereof | |
WO2013109635A1 | Compositions and methods for the treatment of hepatic diseases and disorders |